YU22502A - Fibrinolitički aktivni polipeptid - Google Patents
Fibrinolitički aktivni polipeptidInfo
- Publication number
- YU22502A YU22502A YU22502A YUP22502A YU22502A YU 22502 A YU22502 A YU 22502A YU 22502 A YU22502 A YU 22502A YU P22502 A YUP22502 A YU P22502A YU 22502 A YU22502 A YU 22502A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- fibrinolitically
- active polypeptide
- vivo
- useful
- called
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
- C12N9/6418—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals from snakes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Opisan je fibrinolitički aktivan polipeptid metaloproteinaza (SEQ ID NO:1), njegova primena i postupci i materijali za njegovu proizvodnju rekombinantnom ekspresijom. MRFPSIFTAV LFAASSALAA PVNTTTEDET AOIPAEAVIG YSDLEGDFDV AVLPESNSTN NGLLPINTTI ASIAAKEEGV SLEKREAEAS SIILESGNVN DYEVVYPRKV TPVPRGAVOP KYEDAMOYEF KVNSEPVVLH LEKNKGLFSE DYSETHYSPD GREITTYPLG EDHCYYHGEI ENDADSTASI SACNGLKGHF KLOGEMYLIE PLELSDSEAH AVYKYENVEK EDEAPKMCGV TONWESYEPI KKAFOLNLTK RSFPQRYVQL VIVADHRMNT KYNGDSDKIR QWVHQIVNTI NEIYRPLNIQ FTLVGLEIWS NQDLITVTSV SHDTLASFGN WRETDLLRRQ RHDNAQLLTA IDFDGDTVGL AYVGGMCQLR HSTGVIQDHS AINLLVALTM AHELGHNLGM NHDGNQCHCG ANSCVMAAML SDQPSKLFSD CSKKDYQTFL TVNNPQCILN KP[A fibrinolytically active metalloproteinase polypeptide (called "novel acting thrombolytic") which is useful for blood clot lysis in vivo and methods and materials for its production by recombinant expression are described.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
YUP-2006/0033A RS20060033A (sr) | 1999-10-01 | 2000-09-29 | Fibrinolitički aktivan polipeptid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/411,329 US6261820B1 (en) | 1999-10-01 | 1999-10-01 | Fibronolytically active polypeptide |
Publications (1)
Publication Number | Publication Date |
---|---|
YU22502A true YU22502A (sh) | 2005-07-19 |
Family
ID=23628486
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU59604A YU59604A (sh) | 1999-10-01 | 2000-09-20 | Fibrinolitički aktivan polipeptid |
YU22502A YU22502A (sh) | 1999-10-01 | 2000-09-20 | Fibrinolitički aktivni polipeptid |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU59604A YU59604A (sh) | 1999-10-01 | 2000-09-20 | Fibrinolitički aktivan polipeptid |
Country Status (29)
Country | Link |
---|---|
US (4) | US6261820B1 (sh) |
EP (2) | EP1605049A3 (sh) |
JP (1) | JP2003511034A (sh) |
KR (2) | KR100711312B1 (sh) |
CN (2) | CN101230340A (sh) |
AT (1) | ATE292180T1 (sh) |
AU (1) | AU767827B2 (sh) |
BG (1) | BG106577A (sh) |
BR (1) | BR0014414A (sh) |
CA (1) | CA2386185A1 (sh) |
CZ (1) | CZ298502B6 (sh) |
DE (1) | DE60019147T2 (sh) |
DK (1) | DK1224298T3 (sh) |
EA (2) | EA005944B1 (sh) |
ES (1) | ES2240167T3 (sh) |
HK (1) | HK1049351B (sh) |
HU (1) | HUP0202650A3 (sh) |
IL (1) | IL148787A0 (sh) |
MX (1) | MXPA02003126A (sh) |
NO (1) | NO20021501L (sh) |
NZ (1) | NZ517951A (sh) |
PL (1) | PL355017A1 (sh) |
PT (1) | PT1224298E (sh) |
RS (1) | RS20060033A (sh) |
SG (1) | SG127720A1 (sh) |
SK (1) | SK4232002A3 (sh) |
WO (1) | WO2001025445A1 (sh) |
YU (2) | YU59604A (sh) |
ZA (1) | ZA200202206B (sh) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6440414B1 (en) | 1999-10-01 | 2002-08-27 | Amgen Inc. | Pharmaceutical compositions of fibrinolytic agent |
US6261820B1 (en) | 1999-10-01 | 2001-07-17 | Amgen Inc. | Fibronolytically active polypeptide |
US7033776B2 (en) * | 1999-12-17 | 2006-04-25 | Amgen Inc. | Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
US6455269B1 (en) | 1999-12-17 | 2002-09-24 | Amgen, Inc. | Method for localized administration of fibrinolytic metalloproteinases |
US6523647B2 (en) * | 2001-05-21 | 2003-02-25 | Hydro Mobile Inc. | Elevating platform assembly |
WO2003068047A2 (en) * | 2002-02-11 | 2003-08-21 | Gold - T Tech, Inc. | Method for preventing thrombus formation |
US7016409B2 (en) * | 2003-11-12 | 2006-03-21 | Sony Corporation | Apparatus and method for use in providing dynamic bit rate encoding |
ES2239532B1 (es) * | 2004-02-06 | 2006-11-01 | Proyecto De Biomedicina Cima S.L. | Metodo para evaluar el riesgo y la predisposicion a desarrollar una patologia relacionada con la presencia de autoanticuerpos frente a epcr. |
US20070141625A1 (en) * | 2005-02-03 | 2007-06-21 | Santos Jose H | Method for assessing risk of and predisposition to development of a pathology related to the presence of anti-epcr autoantibodies |
US20070225749A1 (en) | 2006-02-03 | 2007-09-27 | Martin Brian B | Methods and devices for restoring blood flow within blocked vasculature |
EP2403583B1 (en) | 2009-03-06 | 2016-10-19 | Lazarus Effect, Inc. | Retrieval systems |
WO2011056872A2 (en) | 2009-11-03 | 2011-05-12 | Gen9, Inc. | Methods and microfluidic devices for the manipulation of droplets in high fidelity polynucleotide assembly |
WO2012129363A2 (en) | 2011-03-24 | 2012-09-27 | President And Fellows Of Harvard College | Single cell nucleic acid detection and analysis |
EP3191605B1 (en) | 2014-09-09 | 2022-07-27 | The Broad Institute, Inc. | A droplet-based method and apparatus for composite single-cell nucleic acid analysis |
WO2016130647A1 (en) | 2015-02-11 | 2016-08-18 | Lazarus Effect, Inc. | Expandable tip medical devices and methods |
EP3268462B1 (en) | 2015-03-11 | 2021-08-11 | The Broad Institute, Inc. | Genotype and phenotype coupling |
WO2017075297A1 (en) | 2015-10-28 | 2017-05-04 | The Broad Institute Inc. | High-throughput dynamic reagent delivery system |
WO2017075265A1 (en) | 2015-10-28 | 2017-05-04 | The Broad Institute, Inc. | Multiplex analysis of single cell constituents |
US11072816B2 (en) | 2017-05-03 | 2021-07-27 | The Broad Institute, Inc. | Single-cell proteomic assay using aptamers |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2310133A2 (fr) | 1975-05-05 | 1976-12-03 | Fabre Sa Pierre | Nouveau medicament comportant un activateur du plasminogene perfectionne |
US4447236A (en) | 1982-02-05 | 1984-05-08 | Cordis Corporation | Infusion catheter system |
DE3330699A1 (de) * | 1983-08-25 | 1985-03-07 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur gleichzeitigen bestimmung von fibrinogen und fibrinogen-spaltprodukten im plasma |
US4610879A (en) | 1984-01-06 | 1986-09-09 | University Of Southern California | Fibrinolytic enzyme from snake vernom |
CA1237482A (en) | 1984-03-09 | 1988-05-31 | Frank B. Stiles | Catheter for effecting removal of obstructions from a biological duct |
US4755167A (en) | 1984-04-10 | 1988-07-05 | Research Corporation | In vivo method for distribution and stirring of therapeutic agents |
US4837148A (en) | 1984-10-30 | 1989-06-06 | Phillips Petroleum Company | Autonomous replication sequences for yeast strains of the genus pichia |
US4885242A (en) | 1984-10-30 | 1989-12-05 | Phillips Petroleum Company | Genes from pichia histidine pathway and uses thereof |
US4855231A (en) | 1984-10-30 | 1989-08-08 | Phillips Petroleum Company | Regulatory region for heterologous gene expression in yeast |
US4818700A (en) | 1985-10-25 | 1989-04-04 | Phillips Petroleum Company | Pichia pastoris argininosuccinate lyase gene and uses thereof |
US4812405A (en) | 1986-02-18 | 1989-03-14 | Phillips Petroleum Company | Double auxotrophic mutants of Pichia pastoris and methods for preparation |
US5000185A (en) | 1986-02-28 | 1991-03-19 | Cardiovascular Imaging Systems, Inc. | Method for intravascular two-dimensional ultrasonography and recanalization |
ZA889415B (en) | 1987-12-18 | 1989-09-27 | Chiron Corp | Compositions and method for recombinant production of crotalidus venum fibrolase |
WO1990007352A1 (en) | 1989-01-04 | 1990-07-12 | Boston Scientific Corporation | Angioplasty catheter |
US5222941A (en) | 1990-01-12 | 1993-06-29 | Don Michael T Anthony | Method of dissolving an obstruction in a vessel |
EP0438200B1 (en) * | 1990-01-16 | 2002-07-17 | Centro De Ingenieria Genetica Y Biotecnologia | Method for the expression of heterologous genes in the yeast Pichia pastoris, expression vectors and transformed microorganisms |
US5709676A (en) | 1990-02-14 | 1998-01-20 | Alt; Eckhard | Synergistic treatment of stenosed blood vessels using shock waves and dissolving medication |
US5250034A (en) | 1990-09-17 | 1993-10-05 | E-Z-Em, Inc. | Pressure responsive valve catheter |
US5167628A (en) | 1991-05-02 | 1992-12-01 | Boyles Paul W | Aortic balloon catheter assembly for indirect infusion of the coronary arteries |
US5380273A (en) | 1992-05-19 | 1995-01-10 | Dubrul; Will R. | Vibrating catheter |
EP0624642B1 (en) | 1993-05-12 | 1999-01-20 | Indian Council For Medical Research | Novel thrombolytic agent, process for preparing same and its use for the preparation of a thrombi dissolving medicament |
US5370653A (en) | 1993-07-22 | 1994-12-06 | Micro Therapeutics, Inc. | Thrombectomy method and apparatus |
AU692497B2 (en) | 1993-12-17 | 1998-06-11 | Asahi Kasei Pharma Corporation | Soluble thrombomodulin-containing pharmaceutical composition |
US5626564A (en) | 1995-03-31 | 1997-05-06 | Creighton University | Adjustable sideholes catheter |
US6020181A (en) | 1995-05-17 | 2000-02-01 | New York Blood, Inc. | Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase |
US5830468A (en) | 1995-05-17 | 1998-11-03 | The New York Blood Center, Inc. | Fibrin(ogen) degradation by fibrinolytic matrix metalloproteinase |
US5741779A (en) | 1996-05-10 | 1998-04-21 | Xoma Corporation | Antithrombotic materials and methods |
WO1997045105A1 (en) | 1996-05-24 | 1997-12-04 | Angiotech Pharmaceuticals, Inc. | Compositions and methods for treating or preventing diseases of body passageways |
US5951981A (en) * | 1996-12-02 | 1999-09-14 | Diatide, Inc. | Thrombolytic agents with antithrombotic activity |
US6413760B1 (en) * | 1997-04-15 | 2002-07-02 | Genetics Institute, Inc. | Highly purified mocarhagin cobra venom protease polynucleotides endcoding same and related proteases and therapeutic uses thereof |
JP2001526027A (ja) * | 1997-12-09 | 2001-12-18 | ブリストル−マイヤーズ スクイブ カンパニー | フィブリノーゲン変換酵素ハイブリド |
US6440414B1 (en) | 1999-10-01 | 2002-08-27 | Amgen Inc. | Pharmaceutical compositions of fibrinolytic agent |
US6261820B1 (en) | 1999-10-01 | 2001-07-17 | Amgen Inc. | Fibronolytically active polypeptide |
US6455269B1 (en) | 1999-12-17 | 2002-09-24 | Amgen, Inc. | Method for localized administration of fibrinolytic metalloproteinases |
AU2001281081A1 (en) | 2000-08-03 | 2002-02-18 | Zymogenetics Inc. | Disintegrin homologs, zsnk10, zsnk11, and zsnk12 |
-
1999
- 1999-10-01 US US09/411,329 patent/US6261820B1/en not_active Expired - Fee Related
-
2000
- 2000-09-20 YU YU59604A patent/YU59604A/sh unknown
- 2000-09-20 YU YU22502A patent/YU22502A/sh unknown
- 2000-09-29 EP EP05006771A patent/EP1605049A3/en not_active Withdrawn
- 2000-09-29 KR KR1020027004225A patent/KR100711312B1/ko not_active IP Right Cessation
- 2000-09-29 KR KR1020067019636A patent/KR100700753B1/ko not_active IP Right Cessation
- 2000-09-29 EA EA200200410A patent/EA005944B1/ru not_active IP Right Cessation
- 2000-09-29 NZ NZ517951A patent/NZ517951A/en unknown
- 2000-09-29 CN CNA2008100053253A patent/CN101230340A/zh active Pending
- 2000-09-29 DE DE60019147T patent/DE60019147T2/de not_active Expired - Fee Related
- 2000-09-29 BR BR0014414-2A patent/BR0014414A/pt not_active Application Discontinuation
- 2000-09-29 EA EA200400290A patent/EA006487B1/ru unknown
- 2000-09-29 ES ES00965554T patent/ES2240167T3/es not_active Expired - Lifetime
- 2000-09-29 EP EP00965554A patent/EP1224298B1/en not_active Expired - Lifetime
- 2000-09-29 JP JP2001528597A patent/JP2003511034A/ja not_active Withdrawn
- 2000-09-29 CN CNB008163219A patent/CN100357430C/zh not_active Expired - Fee Related
- 2000-09-29 HU HU0202650A patent/HUP0202650A3/hu unknown
- 2000-09-29 CA CA002386185A patent/CA2386185A1/en not_active Abandoned
- 2000-09-29 SK SK423-2002A patent/SK4232002A3/sk not_active Application Discontinuation
- 2000-09-29 CZ CZ20021034A patent/CZ298502B6/cs not_active IP Right Cessation
- 2000-09-29 PL PL00355017A patent/PL355017A1/xx not_active IP Right Cessation
- 2000-09-29 WO PCT/US2000/027029 patent/WO2001025445A1/en active IP Right Grant
- 2000-09-29 SG SG200401889A patent/SG127720A1/en unknown
- 2000-09-29 RS YUP-2006/0033A patent/RS20060033A/sr unknown
- 2000-09-29 AT AT00965554T patent/ATE292180T1/de not_active IP Right Cessation
- 2000-09-29 AU AU76254/00A patent/AU767827B2/en not_active Ceased
- 2000-09-29 MX MXPA02003126A patent/MXPA02003126A/es active IP Right Grant
- 2000-09-29 DK DK00965554T patent/DK1224298T3/da active
- 2000-09-29 IL IL14878700A patent/IL148787A0/xx unknown
- 2000-09-29 PT PT00965554T patent/PT1224298E/pt unknown
-
2001
- 2001-05-01 US US09/846,729 patent/US6617145B2/en not_active Expired - Fee Related
-
2002
- 2002-03-19 ZA ZA200202206A patent/ZA200202206B/en unknown
- 2002-03-26 NO NO20021501A patent/NO20021501L/no not_active Application Discontinuation
- 2002-04-04 BG BG106577A patent/BG106577A/bg unknown
-
2003
- 2003-01-24 HK HK03100667.9A patent/HK1049351B/zh not_active IP Right Cessation
- 2003-05-20 US US10/441,667 patent/US7195903B2/en not_active Expired - Fee Related
-
2007
- 2007-02-06 US US11/702,972 patent/US20080058256A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU22502A (sh) | Fibrinolitički aktivni polipeptid | |
PT1232254E (pt) | Processo para a produção de uma composição de plasmina acidificada reversivelmente inactiva | |
NO910811L (no) | Vevsplasminogen-aktivator med zymogeniske- eller fibrinspesifikke egenskaper. | |
ATE239084T1 (de) | Mutanten der pro-urokinase | |
AU7951798A (en) | Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo | |
ZA927360B (en) | Improved tissue glue prepared by using cryoprecipitate | |
WO1988005081A3 (en) | Novel plasminogen activator | |
HU9402063D0 (en) | Bifunctional urocinase-variants having improved fibrinolytic properties and thrombin-inhibiting activity | |
AU2353688A (en) | Modified tissue plasminogen activator | |
ES2067326T3 (es) | Variante especifica de activador de plasminogeno tisular. | |
Rudenskaya et al. | Studying in vitro fibrinolytic and thrombolytic properties of thiol-dependent serine proteinase from Thermoactinomyces vulgaris. |